Bhopal Covaxin trial participants allege side-effects, irregularities downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
Coronavirus: Volunteer’s death not related to vaccine, says Bharat Biotech
Citing the autopsy report, the company said that the 45-year-old died due to cardio-respiratory failure, resulting from a suspected case of poisoning. Jan 10, 2021 · 11:02 am Image for representation: A health worker takes part in a dry run as part of preparedness for the administration of Covid-19 vaccine. | PTI
Pharmaceutical company Bharat Biotech on Saturday said that the death of a 45-year-old volunteer in Bhopal during the clinical trials of its coronavirus vaccine was not related to the jab, reported
The Hindu.
“The volunteer passed away nine days after the dosing and preliminary reviews by the site indicate that the death is unrelated to the study dosing,” the company said in a statement. “We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded.”
ANI | Updated: Jan 09, 2021 20:24 IST
New Delhi [India], January 9 (ANI): After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the site follow up calls post seven days of his dosing.
With regard to reports of a death in Phase III trials, we would like to state that a volunteer passed away on December 21, 2020, and the death was reported to the People s College of Medical Sciences and Research Centre by the son of the deceased, Bharat Biotech stated.
Volunteer s Death Unrelated To Covaxin: Bharat Biotech We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded, the vaccine major noted. PTI outlookindia.com 2021-01-09T20:56:07+05:30
After the death of a 42-year-old volunteer in Bhopal, who took a dose of Covaxin in the clinical trial of Bharat Biotech s Covaxin, further spurred controversy over the emergency approval of the firm s covid vaccine, Bharat Biotech denied that the vaccine was the cause of the volunteer s death.
Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication.